Variable Univariate analysis Multivariable analysis
OR [95 CI] p-value OR [95 CI] p-value
Initial daily dose
< 800 vs 800 mg 1.95 [0.85-4.5] 0.12 2.15 [0.71-6.57] 0.18
PAZ Cmin at D15
< 27 vs ≥ 27 mg/L 3.09 [1.31-7.28] 0.01 4.21 [1.47-12.12] 0.008
Histological subtype
Leiomyosarcoma vs other 1.22 [0.48-3.07] 0.68 1.99 [0.62-6.40] 0.25
Synovial sarcoma vs other 0.54 [0.15-1.99] 0.35 0.67 [0.14-3.26] 0.62
Tumour grade*
Grade 3 vs 1-2 2.91 [1.03-8.20] 0.04
Metastatic sites
Bone metastasis 2.85 [1.15-7.06] 0.02 2.63 [0.87-7.95] 0.09
Lymph node metastasis 2.78 [1.16-6.70] 0.02 4.55 [1.43-14.46] 0.01
ECOG PS
≥ 2 vs 0-1 3.10 [1.16-8.32] 0.02 1.89 [0.55-6.55] 0.31
Previous treatments
≥ 2 vs 0-1 previous lines 0.93 [0.40-2.18] 0.87
BMI
> 25 vs ≤ 25 kg/m2 2.63 [1.13-6.13] 0.03 3.05 [1.02-9.15] 0.046
Albumin
≥ 35 vs < 35 g/L 0.77 [0.25-2.41] 0.66
NLR
≥ 3.5 vs < 3.5 0.40 [0.17-0.95] 0.04 0.31 [0.10-0.93] 0.04